Clomiphene is a Chemicals product. Key specs — Brand: Chih-Cheng; Origin: China (Mainland).
Product Description
ã€drugs Alias】:clomiphene citrate, clomiphene citrate, ammonium chloride phenol end, so chase, Shu Jingfen ã€English name】:Clomiphene CAS 911-45-5 ã€Specification】:Capsules: 50mg / tablets.
Tablet: 50mg / piece ã€Product category】:Promoting hormone medicines ã€Pharmacological effects】: 1, clomiphene in experimental animals have a weak estrogenic activity, and in the human body, there the role of anti-estrogenic activity, can stimulate ovulation.
2, low dose can promote the secretion of anterior pituitary gonadotropin, and induce ovulation. High doses inhibited the release of pituitary gonadotropin on spermatogenesis in men with promoting the role of oligospermia effective.
3, to promote the secretion of male sex hormones, increased serum testosterone levels and increase the number and expertise in energy, so that infertile men have sperm. ã€Indications】: For anovulatory infertility, luteal phase defect, polycystic ovary, etc. have a certain effect. Of premenstrual stress disorder, galactorrhea disease can improve symptoms.
Of primary pituitary or ovarian failure caused by infertility is invalid. Sperm can also be used for the lack of male infertility, ã€Dose and usage】: a menstrual period by 5 days beginning from day 1 50mg, even for 5 days; no menstruation by any 1 day, 1 day 50mg, even for 5 days.
Usually around 7 days after ovulation medication after 3 weeks of natural walking. And even served as a course of 3 cycles. For male infertility, day 1 25mg, and even served 25 days for treatment.
5 days after drug withdrawal, taking repeated until the sperm count to normal standards, generally 3 to 12 months good effect. ã€Adverse reactions】: common are ovarian enlargement and cyst formation, facial flushing (menopause syndrome and similar), abdominal and pelvic discomfort or pain, breast swelling, weight gain, dizziness, increased urine output, transient blurred vision, allergic skin rash, reversible hair loss, insomnia, depression and liver dysfunction.
Liver disease and bleeding in patients without identification of the disabled.
